Patients with hereditary ATTR amyloidosis experience an increasing burden of illness as the disease progresses

被引：0
|
作者：
David Adams
Oved Amitay
Teresa Coelho
机构：
[1] Univ Paris-Sud,Hopital de Bicetre, Service de Neurologie and Centre de Reference des Neuropathies Amyloides Familiales (NNERF), INSERM U1195
[2] APHP,Commercial
[3] Alnylam Pharmaceuticals,Unidade Clinica de Paramiloidose
[4] Hospital de Santo Antonio,undefined
来源：
Orphanet Journal of Rare Diseases | / 10卷 / Suppl 1期
关键词：
Employment Status; Amyloidosis; Disease Burden; Polyneuropathy; Perceive Health Status;
D O I：
10.1186/1750-1172-10-S1-P58
中图分类号：
学科分类号：
摘要：
引用
收藏
相关论文
共 50 条
  • [41] Characterizing the High Disease Burden of Transthyretin Amyloidosis for Patients and Caregivers
    Stewart, Michelle
    Shaffer, Shannon
    Murphy, Brian
    Loftus, Jane
    Alvir, Jose
    Cicchetti, Michael
    Lenderking, William R.
    NEUROLOGY AND THERAPY, 2018, 7 (02) : 349 - 364
  • [42] Characterizing the High Disease Burden of Transthyretin Amyloidosis for Patients and Caregivers
    Michelle Stewart
    Shannon Shaffer
    Brian Murphy
    Jane Loftus
    Jose Alvir
    Michael Cicchetti
    William R. Lenderking
    Neurology and Therapy, 2018, 7 : 349 - 364
  • [43] FINANCIAL TOXICITY AND PATIENT-REPORTED ECONOMIC BURDEN IN PATIENTS WITH ATTR: RESULTS FROM AMYLOIDOSIS RESEARCH CONSORTIUM'S ATTR TREATMENT AFFORDABILITY PATIENT AND CAREGIVER SURVEY
    Rebello, Sabrina
    Hsu, Kristen
    Nativi-Nicolau, Jose
    Karam, Chafic
    Grogan, Martha
    Lousada, Isabelle
    Maurer, Mathew S.
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2022, 79 (09) : 301 - 301
  • [44] ONE-YEAR EXPERIENCE OF PATISIRAN TREATMENT IN PATIENTS WITH HEREDITARY TRANSTHYRETIN AMYLOIDOSIS
    Guaraldi, Pietro
    Cani, Ilaria
    Rinaldi, Rita
    Masullo, Marco
    Gagliari, Christian
    Longhi, Simone
    Caponetti, Giuseppe
    Galie, Nazzareno
    Cortelli, Pietro
    JOURNAL OF THE PERIPHERAL NERVOUS SYSTEM, 2023, 28 : S32 - S32
  • [45] Trial design and rationale for APOLLO, a Phase 3, placebo-controlled study of patisiran in patients with hereditary ATTR amyloidosis with polyneuropathy
    David Adams
    Ole B. Suhr
    Peter J. Dyck
    William J. Litchy
    Raina G. Leahy
    Jihong Chen
    Jared Gollob
    Teresa Coelho
    BMC Neurology, 17
  • [46] Trial design and rationale for APOLLO, a Phase 3, placebo-controlled study of patisiran in patients with hereditary ATTR amyloidosis with polyneuropathy
    Adams, David
    Suhr, Ole B.
    Dyck, Peter J.
    Litchy, William J.
    Leahy, Raina G.
    Chen, Jihong
    Gollob, Jared
    Coelho, Teresa
    BMC NEUROLOGY, 2017, 17
  • [47] Increasing burden of liver disease in patients with HIV infection
    Joshi, Deepak
    O'Grady, John
    Dieterich, Doug
    Gazzard, Brian
    Agarwal, Kosh
    LANCET, 2011, 377 (9772): : 1198 - 1209
  • [48] Amyloid detection in the transverse carpal ligament of patients with hereditary ATTR V30M amyloidosis and carpal tunnel syndrome
    Samoes, Raquel
    Taipa, Ricardo
    Valdrez, Katia
    Goncalves, Isabel
    Pires, Manuel Melo
    da Silva, Ana Martins
    Coelho, Teresa
    AMYLOID-JOURNAL OF PROTEIN FOLDING DISORDERS, 2017, 24 (02): : 73 - 77
  • [49] Is polypharmacy an increasing burden in chronic kidney disease? The German experience COMMENT
    Parker, Kathrine
    Wong, Joanne
    CLINICAL KIDNEY JOURNAL, 2019, 12 (05) : 659 - 662
  • [50] Psychosocial burden and professional and social support in patients with hereditary transthyretin amyloidosis (ATTRv) and their relatives in Italy
    Magliano, Lorenza
    Obici, Laura
    Sforzini, Claudia
    Mazzeo, Anna
    Russo, Massimo
    Cappelli, Francesco
    Fenu, Silvia
    Luigetti, Marco
    Tagliapietra, Matteo
    Gemelli, Chiara
    Leonardi, Luca
    Tozza, Stefano
    Pradotto, Luca Guglielmo
    Citarelli, Giulia
    Mauro, Alessandro
    Manganelli, Fiore
    Antonini, Giovanni
    Grandis, Marina
    Fabrizi, Gian Maria
    Sabatelli, Mario
    Pareyson, Davide
    Perfetto, Federico
    Merlini, Giampaolo
    Vita, Giuseppe
    ORPHANET JOURNAL OF RARE DISEASES, 2021, 16 (01)
12345